Today’s Solutions: December 08, 2023

Most young people hardly think about their joints. They wonder why adults may groan as they pull themselves up from the couch, wince while climbing steep stairs, or say something along the lines of “oh, my knees!” at random—until, that is, the day inevitably comes when they experience joint pain.

An ache that affects us all

For more than 32 million Americans and millions more around the world, the aches and pains of gradual wear and tear develop into osteoarthritis, the most common form of arthritis that occurs when the cartilage meant to protect the ends of bones wears down over time. A form of osteoarthritis, called post-traumatic osteoarthritis (PTOA), is the consequence of injury or damage to the joint and accounts for 10 percent of all osteoarthritis cases. This leads to chronic discomfort and pain that cannot be slowed or stopped by any kind of therapeutic method, due to the inherent difficulties in having drugs reach the affected joints and staying there for a long enough period to suppress the inflammation and promote the regeneration of cartilage.

Saving our joints

A team of scientists from New York University has come up with a new treatment for PTOA: an injectable gel that can stop this form of osteoarthritis from worsening by delivering drugs to damaged joints that keep inflammation under control.

The key ingredient to this solution is a compound that is made up of polypeptides, proteins, and an anti-inflammatory growth factor called Atsttrin. This compound was made into an injectable polymer gel, which, at body temperature, form a porous network that produces the ideal biomechanics environment to promote the regeneration of tissues while slowly releasing the anti-inflammatory growth factors.

So far, this method has been tested through in vitro experiments and then through in vivo experiments on rabbits. The gel successfully protected the rabbits against the onset or progression of PTO in their anterior cruciate ligaments. It’s also worth noting that the gel is based on proteins—not on synthetic materials. This means that it should be well-tolerated by the body and biodegradable within a matter of weeks.

Though this treatment is still in its early stages, the scientists believe that these promising results could provide a blueprint, not just for PTOA treatment but for other conditions involving damaged or inflamed joints.

Source study: Biomaterials—Injectable recombinant block polymer gel for sustained delivery of therapeutic protein in post-traumatic osteoarthritis

Solutions News Source Print this article
More of Today's Solutions

Listen to this fascinating piece of ambient music composed by stars

Though we can’t hear them, stars propagate some incredibly soothing soundscapes through the vacuum of space. And for the first time, music composed from ...

Read More

Reduce home food waste part II: The fridge

Food waste continues to be a huge problem all over the world. Luckily, according to the experts, you can help improve the global food ...

Read More

Pufferfish-inspired houses help lake village adapt to sea-level rise

We decided to dust off this older article with an incredible solution to sea-level rise.  Situated entirely on water, the lake village of Ganvie ...

Read More

MIT researchers develop cost-effective battery made of common materials

The environmental benefits of using electricity rather than fossil fuels to power our world goes without saying— however, the process of electrifying everything has ...

Read More